SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (9838)10/21/1997 2:48:00 AM
From: Andrew H  Read Replies (1) | Respond to of 32384
 
Ligand Pharmaceuticals Inc., San Diego, agreed to a drug-development collaboration with Eli Lilly & Co. that has a potential value of about $200 million to Ligand over eight years, Ligand said.

The estimates are starting to go up. From $175 to 200M. Now if we could only get to the $400M figure. But if you are correct about this mystery drug, that may come soon and give the stock a nice bounce.